Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03566524 · ClinicalTrials.gov registry record · NA
Study of Arginine and Nitric Oxide in Patients With Diabetes
A NA study, sponsored by Baylor College of Medicine.
- Completed
- Registry status
- NA
- Development phase
- 10
- Enrollment target
NCT03566524 is a NA study that has completed, run by Baylor College of Medicine. The registered enrollment target is 10 participants.
The verdict
NCT03566524, a NA study, has completed, sponsored by Baylor College of Medicine.
- COMPLETED
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
Study Summary
This study will test the effect of citrulline versus placebo supplementation in ketosis-prone diabetes (KPD) patients on arginine and nitric oxide production and on glucose- and arginine-stimulated insulin secretion and arterial flow-mediated dilation.
Interventions
- DIETARY_SUPPLEMENT Alanine
- DIETARY_SUPPLEMENT Citrulline
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2018-07-01 |
| Est. Completion | 2022-06-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03566524
The ClinicalTrials.gov registry entry for NCT03566524 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Baylor College of Medicine, which has 616 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Alanine is the first listed.
NCT03566524 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03566524 about?
NCT03566524 is a clinical study titled "Study of Arginine and Nitric Oxide in Patients With Diabetes". This study will test the effect of citrulline versus placebo supplementation in ketosis-prone diabetes (KPD) patients on arginine and nitric oxide production and on glucose- and arginine-stimulated insulin secretion and arterial flow-mediated dilation.
What is the current status of trial NCT03566524?
This trial is currently completed. It is a NA study. The enrollment target is 10 participants. The study started on 2018-07-01. Estimated completion is 2022-06-30.
What interventions are being tested in trial NCT03566524?
The interventions under investigation include: Alanine (DIETARY_SUPPLEMENT), Citrulline (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT03566524?
This trial is sponsored by Baylor College of Medicine, which has 616 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.